awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53802223-C22F278F-6127-40F8-90CA-F50F5C14A52D
Q53802223-C22F278F-6127-40F8-90CA-F50F5C14A52D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53802223-C22F278F-6127-40F8-90CA-F50F5C14A52D
S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102).
P2860
Q53802223-C22F278F-6127-40F8-90CA-F50F5C14A52D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53802223-C22F278F-6127-40F8-90CA-F50F5C14A52D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6742b763b2649ba50788cc7f02568311b2a1a351
P2860
Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer.